| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |